aldosterone has been researched along with verapamil in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 39 (60.94) | 18.7374 |
1990's | 13 (20.31) | 18.2507 |
2000's | 8 (12.50) | 29.6817 |
2010's | 3 (4.69) | 24.3611 |
2020's | 1 (1.56) | 2.80 |
Authors | Studies |
---|---|
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
Chieli, E; Romiti, N; Tramonti, G | 1 |
Baumann, K; Stiefl, N | 1 |
Caron, G; Ermondi, G | 1 |
Andrisano, V; Barril, X; Bartolini, M; Carreiras, Mdo C; de los Ríos, C; García, AG; Huertas, O; León, R; López, B; López, MG; Luque, FJ; Marco-Contelles, J; Rodríguez-Franco, MI; Samadi, A; Villarroya, M | 1 |
Alcaro, S; Bagetta, D; Borges, F; Cagide, F; Oliveira, PJ; Ortuso, F; Pérez, C; Reis, J; Rodríguez-Franco, MI; Teixeira, J; Uriarte, E; Valencia, ME | 1 |
Fitzpatrick, SC; McKenna, TJ | 1 |
Elder, HY; Fraser, R; Kenyon, CJ; Pediani, JD; Shepherd, RM | 1 |
August, P; Laragh, JH; Lenz, T; Müller, FB; Sotelo, JE | 1 |
Lembke, JM; Saelens, DA; Zawada, ET | 1 |
Fagher, B; Henningsen, N; Hulthén, L; Katzman, P; Thulin, T | 1 |
Coghlan, JP; Denton, DA; Hardy, KJ; Johnson, EI; McDougall, JG; Scoggins, BA; Wright, RD | 1 |
Delarue, C; Escher, E; Feuilloley, M; Leboulenger, F; Lihrmann, I; Netchitailo, P; Vaudry, H | 1 |
Braley, LM; Menachery, A; Schiebinger, RJ; Williams, GH | 1 |
Coghlan, JP; Denton, DA; Johnson, EI; McDougall, JG; Scoggins, BA; Wright, RD | 2 |
Eiskjaer, H; Jespersen, B; Pedersen, EB; Rasmussen, LM | 2 |
Andonova, K; Koev, D; Matrozov, P; Stoeva, I; Tcharaktchiev, D; Zacharieva, S | 1 |
Orynchak, MA | 1 |
Horiuchi, T; Shimizu, N; Tanaka, K | 1 |
Lohmeier, TE; Montani, JP; Rushing, EL; Smith, MJ | 1 |
Zofková, I | 1 |
Guthrie, GP; Kotchen, TA | 1 |
Campbell, L; Elliott, HL; Meredith, PA; Reid, JL | 1 |
Aupetit, B; Blanchouin-Emeric, N; Defaye, G; Zenatti, M | 1 |
Mantero, F; Murgia, A; Opocher, G; Rocco, S | 1 |
Boscaro, M; D'Agostino, D; Mantero, F; Menegus, A; Murgia, A; Opocher, G; Rocco, S | 1 |
Amiel, A; Boutaud, P; Demange, J; Herpin, D; Wajman, A | 1 |
Blower, A; Campbell, CB; Derkx, FH; Meredith, PA; Reid, JL | 1 |
Gerber, A; Laederach, K; Weidmann, P | 1 |
Delarue, C; Leboulenger, F; Lihrmann, I; Netchitailo, P; Vaudry, H | 1 |
Ganguly, A; Hampton, T | 1 |
Danielsen, H; Pedersen, EB; Sørensen, SS; Thomsen, OO | 1 |
Bentley, PJ | 1 |
Agabiti-Rosei, E; Alicandri, CL; Beschi, M; Castellano, M; Corea, L; Fariello, R; Muiesan, G; Romanelli, G | 1 |
Catt, KJ; Fakunding, JL | 1 |
Buemi, M; Ciraolo, O; Costa, G; De Pasquale, R; Frisina, N; Lasco, A; Nicita Mauro, V | 1 |
Genest, J; Gutkowska, J; Lis, M; Schiffrin, EL | 1 |
Balla, T; Hunyady, L; Spät, A | 1 |
Birkenhäger, WH; de Leeuw, PW; van Soest, GA | 1 |
Algueti, A; Blum, M; Chayen, R; Fiterman, A; Hoerer, E; Kisch, E; Laurian, L | 1 |
Guthrie, GP; Kotchen, TA; McAllister, RG | 1 |
Guthrie, GP; Holladay, FP; Kotchen, TA; Roy, MW | 1 |
Aguilera, G; Catt, KJ; Finkel, MS; Keiser, HR | 1 |
Hampl, R; Roztocil, K; Zofková, I | 1 |
McClelland, DL; Rosenkranz, RP; Roszkowski, AP | 1 |
Capponi, AM; Jornot, L; Lew, PD; Vallotton, MB | 1 |
Balla, T; Enyedi, P; Spät, A | 1 |
Bittar, EE; Nwoga, J | 1 |
Adegbile, IA; Cervenka, JH; Kailasam, MT; Kennedy, BP; O'Connor, DT; Parmer, RJ; Wu, RA; Ziegler, MG | 1 |
Chrysant, SG; Fox, AA; Stimpel, M | 1 |
Fineberg, NS; Wagner, UL; Weinberger, MH | 1 |
Bocciolone, M; Boselli, L; Comerio, G; Cuspidi, C; Leonetti, G; Lonati, L; Sampieri, L; Zanchetti, A | 1 |
Ezra, D; Peleg, E; Rosenthal, T; Shamiss, A | 1 |
Cozza, EN; Lantos, CP; Pecci, A; Romero, DG | 1 |
Malendowicz, LK; Nowak, KW; Nussdorfer, GG; Rebuffat, P | 1 |
Condliffe, SB; Doolan, CM; Harvey, BJ | 1 |
Hong, T; Sun, N; Yang, X; Zhang, R | 1 |
Desir, GV; Hayslett, JP; Segal, AS | 1 |
Blengio, GS; Ciacciarelli, A; Corrocher, R; Falcone, S; Olivieri, O; Pizzolo, F; Signorelli, D | 1 |
Bandulik, S; Barhanin, J; Beuschlein, F; Humberg, E; Penton, D; Reincke, M; Sterner, C; Stindl, J; Tauber, P; Tegtmeier, I; Warth, R | 1 |
Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
Alnazer, RM; de Leeuw, PW; Kroon, AA; Veldhuizen, GP | 1 |
3 review(s) available for aldosterone and verapamil
Article | Year |
---|---|
Effects of calcium on renin and aldosterone.
Topics: Aldosterone; Animals; Biological Transport; Calcium; Calcium Chloride; Calcium Gluconate; Calcium, Dietary; Humans; Renin; Verapamil | 1988 |
Calcium antagonists in the treatment of hypertension: a critical overview.
Topics: Aldosterone; Blood Pressure; Calcium; Calcium Channel Blockers; Cardiac Output; Catecholamines; Heart Rate; Hemodynamics; Humans; Hypertension; Nifedipine; Renin; Verapamil | 1985 |
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
11 trial(s) available for aldosterone and verapamil
Article | Year |
---|---|
Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized study.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Renin; Verapamil | 1990 |
Effect of verapamil on renin-angiotensin-aldosterone system, urinary 6-keto prostaglandin F1 alpha and aldosterone response to metoclopramide in normal man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Humans; Male; Metoclopramide; Renin-Angiotensin System; Verapamil | 1989 |
The combination of prazosin and verapamil in the treatment of essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Catecholamines; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Renin; Verapamil | 1988 |
Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II, aldosterone and arginine vasopressin in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Blood Pressure; Body Weight; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Potassium; Renal Circulation; Sodium; Verapamil | 1985 |
Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Blood Volume; Calcium Channel Blockers; Catecholamines; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Pyridines; Renin; Verapamil | 1982 |
Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension.
Topics: Aldosterone; Analysis of Variance; Autonomic Nervous System; Baroreflex; Calcium Channel Blockers; Cardiography, Impedance; Chromogranin A; Chromogranins; Epinephrine; Felodipine; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Renin; Sympathetic Nervous System; Time Factors; Verapamil | 1995 |
Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Renin; Tetrahydroisoquinolines; Verapamil | 1995 |
Salt sensitivity and the blood pressure response to verapamil.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Middle Aged; Renin; Sodium Chloride; Sodium, Dietary; Verapamil | 1994 |
Antihypertensive and humoral effects of verapamil and lacidipine in combination in hypertensive patients.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Renin; Verapamil | 1993 |
The role of atrial natriuretic peptide in the diuretic effect of Ca2+ entry blockers.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Calcium Channel Blockers; Diuretics; Felodipine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuresis; Nifedipine; Renin; Renin-Angiotensin System; Verapamil | 1993 |
The effects of verapamil SR and bisoprolol on reducing the sympathetic nervous system's activity.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Endothelin-1; Epinephrine; Female; Hand Strength; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Renin; Sympathetic Nervous System; Sympatholytics; Verapamil | 2000 |
50 other study(ies) available for aldosterone and verapamil
Article | Year |
---|---|
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Western; Cell Line, Transformed; DNA Primers; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation; Humans; Kidney Tubules, Proximal; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2002 |
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
Topics: Acetates; Alcohols; Algorithms; Cholinergic Agents; Hydrocarbons, Acyclic; Hydrocarbons, Aromatic; Ketones; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Receptor, Muscarinic M2; Receptors, Muscarinic; Steroids; Transcortin | 2003 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Butyrylcholinesterase; Calcium; Calcium Channel Blockers; Catalytic Domain; Cell Death; Cell Line, Tumor; Cholinesterase Inhibitors; Cytosol; Dihydropyridines; Humans; Hydrogen Peroxide; Kinetics; Ligands; Models, Molecular; Peptide Fragments; Permeability; Tacrine | 2009 |
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Topics: Alzheimer Disease; Blood-Brain Barrier; Cholinesterase Inhibitors; Cholinesterases; Chromones; Drug Design; Hep G2 Cells; Humans; Ligands; Molecular Docking Simulation; Molecular Targeted Therapy; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 2018 |
Evidence for a tonic inhibitory role of nifedipine-sensitive calcium channels in aldosterone biosynthesis.
Topics: Aldosterone; Animals; Calcium Channels; Cattle; Cells, Cultured; Nifedipine; Potassium; Verapamil; Zona Glomerulosa | 1992 |
The role of potassium and other ions in the control of aldosterone synthesis.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Cattle; Chlorine; Electron Probe Microanalysis; Phosphorus; Potassium; Potassium Channels; Sodium; Sodium-Potassium-Exchanging ATPase; Verapamil | 1991 |
Hemodynamic responses to verapamil monotherapy in patients with renal disease.
Topics: Adult; Aged; Aldosterone; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Regional Blood Flow; Renin-Angiotensin System; Vascular Resistance; Verapamil | 1991 |
Influence of calcium infusion on plasma atrial natriuretic peptide in conscious dogs: intervention with calcium antagonist, verapamil.
Topics: Acute Disease; Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium Chloride; Dogs; Female; Heart Rate; Hypercalcemia; Verapamil | 1990 |
Ca antagonists do not alter aldosterone secretion during established Na depletion.
Topics: Adrenal Glands; Aldosterone; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Edetic Acid; Female; Gallopamil; Hydrocortisone; Indenes; Ion Channels; Lanthanum; Nifedipine; Nisoldipine; Ryanodine; Sheep; Sodium; Verapamil | 1985 |
Role of calcium in stimulus-secretion coupling on isolated frog interrenal gland.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Bucladesine; Calcium; Cobalt; Colforsin; Corticosterone; In Vitro Techniques; Interrenal Gland; Ion Channels; Male; Rana ridibunda; Verapamil | 1986 |
Unique calcium dependencies of the activating mechanism of the early and late aldosterone biosynthetic pathways in the rat.
Topics: Adrenal Cortex; Aldosterone; Animals; Calcium; Female; Ion Channels; Lanthanum; Nifedipine; Rats; Rats, Inbred Strains; Verapamil | 1986 |
Role of Ca2+ in response of aldosterone to stimulation by angiotensin II in vivo.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Hydrocortisone; Lanthanum; Nifedipine; Nisoldipine; Sheep; Verapamil | 1988 |
Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Circadian Rhythm; Creatinine; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension, Renal; Kidney Function Tests; Lipoproteins; Male; Middle Aged; Verapamil | 1989 |
[The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension].
Topics: Aged; Aldosterone; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; Middle Aged; Nucleotides, Cyclic; Potassium; Renin; Sodium; Verapamil | 1989 |
Mechanism of action of aldosterone release by prostaglandin E in isolated rat adrenal glomerulosa cells.
Topics: ADP-Ribosylation Factors; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Calmodulin; Cells, Cultured; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Egtazic Acid; Male; Membrane Proteins; Prostaglandins E; Rats; Rats, Inbred Strains; Verapamil | 1985 |
Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Dogs; Drug Evaluation, Preclinical; Hypertension; Kidney; Male; Verapamil; Water-Electrolyte Balance | 1989 |
Sustained release verapamil in renal hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Verapamil | 1988 |
The effect of long-term verapamil treatment on the secretion of cortisol and aldosterone in subjects with normal and high blood pressure.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hypertension; Male; Middle Aged; Raynaud Disease; Time Factors; Verapamil | 1985 |
Verapamil directly inhibits aldosterone synthesis by adrenal mitochondria in vitro.
Topics: Adrenal Glands; Aldosterone; Animals; Ducks; Kinetics; Mitochondria; Oxygen Consumption; Verapamil | 1988 |
Effect of verapamil on aldosterone secretion in primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Verapamil | 1987 |
Effect of verapamil on the aldosterone-stimulating properties of metoclopramide: in vitro and in vivo studies.
Topics: Adrenal Glands; Adult; Aldosterone; Angiotensin II; Animals; Female; Humans; In Vitro Techniques; Metoclopramide; Rats; Rats, Inbred Strains; Verapamil | 1986 |
Effect of a calcium antagonist: verapamil on resting blood pressure and pressor response to dynamic exercise.
Topics: Adult; Aldosterone; Blood Pressure; Catecholamines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Renin; Verapamil | 1985 |
The effects of lead on the renin-angiotensin system.
Topics: Aldosterone; Animals; Blood Pressure; Diltiazem; Drug Interactions; Erythrocytes; Heart Rate; In Vitro Techniques; Kidney Cortex; Lead; Male; Organometallic Compounds; Rabbits; Renin; Renin-Angiotensin System; Verapamil | 1985 |
Effect of calcium on corticosteroid secretion by isolated frog interrenal gland.
Topics: Adrenal Glands; Aldosterone; Animals; Calcimycin; Calcium; Corticosterone; Interrenal Gland; Kinetics; Male; Potassium; Rana ridibunda; Verapamil | 1985 |
Calcium-dependence of serotonin-mediated aldosterone secretion and differential effects of calcium antagonists.
Topics: Adrenal Cortex; Aldosterone; Animals; Calcium; Calcium Channel Blockers; Diltiazem; In Vitro Techniques; Male; Nifedipine; Rats; Rats, Inbred Strains; Serotonin; Verapamil | 1985 |
Effects of verapamil on the short-circuit current of an epithelial membrane: the toad urinary bladder.
Topics: Aldosterone; Amphotericin B; Animals; Biological Transport; Bufo marinus; Calcium; Colon; Cyclic AMP; Membrane Potentials; Osmosis; Oxygen Consumption; Skin; Sodium; Urinary Bladder; Vasopressins; Verapamil | 1974 |
Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum nd verapamil.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Calcium; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Lanthanum; Potassium; Rats; Verapamil | 1980 |
[Aldosterone production in vitro by angiotensin II: the role of Ca++].
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Cattle; Cyclic AMP; In Vitro Techniques; Indomethacin; Perfusion; Prostaglandins; Verapamil | 1980 |
Role of Ca2+ in response of adrenal glomerulosa cells to angiotensin II, ACTH, K+, and ouabain.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Calcium; Dose-Response Relationship, Drug; Kinetics; Lanthanum; Ouabain; Potassium; Rats; Verapamil | 1981 |
Possible role of calcium uptake and calmodulin in adrenal glomerulosa cells: effects of verapamil and trifluoperazine.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Bucladesine; Calcium; Calcium-Binding Proteins; Calmodulin; In Vitro Techniques; Male; Potassium; Rats; Rats, Inbred Strains; Trifluoperazine; Verapamil | 1982 |
Aldosterone response to antihypertensive treatment.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Dipeptides; Enalapril; Ethanolamines; Humans; Hypertension; Middle Aged; Prazosin; Pyridazines; Renin; Renin-Angiotensin System; Vasodilator Agents; Verapamil | 1982 |
Verapamil and induced cortisol, aldosterone, TSH secretion.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Humans; Hydrocortisone; Middle Aged; Thyrotropin; Verapamil | 1983 |
Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Calcium; Humans; Hydrocortisone; Male; Renin; Verapamil | 1983 |
Effects of verapamil on renin and aldosterone in the dog and rat.
Topics: Aldosterone; Animals; Blood Pressure; Chlorides; Dogs; Female; Kidney; Kinetics; Male; Papaverine; Potassium; Rats; Renin; Sodium; Verapamil | 1983 |
[3H]nitrendipine binding to adrenal capsular membranes.
Topics: Adrenal Medulla; Aldosterone; Animals; Binding Sites; Binding, Competitive; Diltiazem; Kinetics; Membranes; Nifedipine; Nitrendipine; Rats; Verapamil | 1984 |
Adrenocortical function in the course of long-term verapamil treatment.
Topics: Adrenal Cortex; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hypertension; Male; Middle Aged; Raynaud Disease; Time Factors; Verapamil | 1984 |
Effects of nicardipine, nifedipine, verapamil, and diltiazem on urine volume, sodium and potassium excretion and plasma aldosterone levels in the rat.
Topics: Aldosterone; Animals; Calcium Channel Blockers; Diltiazem; Kidney; Male; Natriuresis; Nicardipine; Nifedipine; Potassium; Rats; Rats, Inbred WKY; Urine; Verapamil | 1984 |
Calcium antagonists and stimulus-secretion coupling of aldosterone.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Nifedipine; Nisoldipine; Potassium; Sheep; Sodium; Transplantation, Autologous; Verapamil | 1984 |
Correlation between cytosolic free Ca2+ and aldosterone production in bovine adrenal glomerulosa cells. Evidence for a difference in the mode of action of angiotensin II and potassium.
Topics: Adrenal Cortex; Aldosterone; Aminoquinolines; Angiotensin II; Animals; Calcium; Cattle; Cytosol; Ethers; Fluorescent Dyes; Ionomycin; Kinetics; Nifedipine; Potassium; Saralasin; Spectrometry, Fluorescence; Verapamil | 1984 |
Role of calcium ions and calmodulin in the aldosterone stimulating action of prostaglandin E2.
Topics: Adrenal Glands; Aldosterone; Animals; Calcium; Calcium-Binding Proteins; Calmodulin; Dinoprostone; Dose-Response Relationship, Drug; Male; Osmolar Concentration; Prostaglandins E; Rats; Rats, Inbred Strains; Trifluoperazine; Verapamil | 1982 |
Stimulation by injected guanosine triphosphate of the sodium efflux in barnacle muscle fibres pre-exposed to aldosterone.
Topics: Aldosterone; Animals; Biological Transport; Guanosine Triphosphate; In Vitro Techniques; Muscles; Ouabain; Sodium; Thoracica; Verapamil | 1981 |
Mechanisms of action of endothelin-1 in rat adrenal.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aldosterone; Animals; Calcium; Calcium Channels; Cattle; Cells, Cultured; Cholesterol; Diglycerides; Endothelin-1; Male; Ouabain; Peptides, Cyclic; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Sodium-Potassium-Exchanging ATPase; Verapamil; Viper Venoms; Zona Glomerulosa | 1998 |
Corticotropin-inhibiting peptide enhances aldosterone secretion by dispersed rat zona glomerulosa cells.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Dose-Response Relationship, Drug; Drug Interactions; Female; Hormone Antagonists; Humans; Peptide Fragments; Rats; Rats, Wistar; Saralasin; Verapamil; Zona Glomerulosa | 1998 |
Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Aldosterone; Animals; Calcium; Colforsin; Colon; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Estradiol; Female; Indoles; Isoenzymes; Male; Maleimides; Membranes; Nifedipine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Testosterone; Verapamil | 2000 |
On the natriuretic effect of verapamil: inhibition of ENaC and transepithelial sodium transport.
Topics: Aldosterone; Animals; Biological Transport, Active; Calcium Channel Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Electrophysiology; Epithelial Sodium Channels; Epithelium; In Vitro Techniques; Insulin; Kidney; Kidney Tubules, Collecting; Natriuresis; Nifedipine; Oocytes; Patch-Clamp Techniques; Sodium; Sodium Channel Blockers; Sodium Channels; Vasopressins; Verapamil; Xenopus laevis | 2002 |
Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Female; Humans; Hypertension; Male; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Renin; Verapamil | 2008 |
Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Amiloride; Barium; Bee Venoms; Calcium; Cell Line, Tumor; Cytosol; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation, Neoplastic; Humans; Mutation; Patch-Clamp Techniques; Permeability; Potassium; Protein Isoforms; RNA; Sodium; Verapamil | 2014 |
The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof.
Topics: Aldosterone; Antihypertensive Agents; Doxazosin; Humans; Hydralazine; Hyperaldosteronism; Hypertension; Renin; Retrospective Studies; Verapamil | 2023 |